Skip to main content
Elliot Androphy, MD, Dermatology, Indianapolis, IN

ElliotJAndrophyMD

Dermatology Indianapolis, IN

Kampen-Norins Professor and Chair

Dr. Androphy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Androphy's full profile

Already have an account?

  • Office

    550 University Blvd
    Ste 3240
    Indianapolis, IN 46202
    Phone+1 317-944-7744
    Fax+1 317-944-7051

Summary

  • Dr. Elliot Androphy, based in Indianapolis, specializes in Dermatology. He completed his medical education at the University of Rochester School of Medicine and Dentistry, and his dermatology residencies at the National Institutes of Health Clinical Center and UPMC Medical Education. Dr. Androphy has held positions at the University of Massachusetts Medical School and Tufts Medical Center. He served as Chair of the Department of Dermatology at the Indiana University School of Medicine from 2010-2022, where he continues his research projects. His research focuses on papillomaviruses, spinal muscular atrophy, DNA-binding proteins, splicing, transcription and discovery of new drugs, with various publications in reputable scientific journals. He is recognized by the American Academy of Microbiology and the American Academy of Dermatology as a Fellow.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Dermatology, 1982 - 1986
  • UPMC Medical Education
    UPMC Medical EducationResidency, Dermatology, 1980 - 1982
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1979

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2010 - 2025
  • Dermatology
    American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Fellow American Academy of Microbiology, 2022
  • Fellow (FAAD) American Academy of Dermatology

Publications & Presentations

PubMed

Press Mentions

  • Kovina Therapeutics Receives National Cancer Institute Grant to Advance Human Papillomavirus Cancer Treatment
    Kovina Therapeutics Receives National Cancer Institute Grant to Advance Human Papillomavirus Cancer TreatmentJune 27th, 2022
  • Grant Announcement: Cure SMA Awards $150,000 Grant to Timra Gilson, Ph.D., Indiana University
    Grant Announcement: Cure SMA Awards $150,000 Grant to Timra Gilson, Ph.D., Indiana UniversityMarch 5th, 2020

Grant Support

  • Functions Of Papillomavirus E6National Cancer Institute2010–2012
  • Small Molecule Inhibitors Of Oncogenic Human PapillomavirusNational Cancer Institute2011
  • Control Of Papillomavirus Expression And TransformationNational Cancer Institute2010–2011
  • Cooperative LEAD Development Program For Treatment Of Spinal Muscular AtrophyEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
  • Testing Compounds That Increase SMN Levels For Efficacy In Mouse Models Of SMANational Institute Of Neurological Disorders And Stroke2010
  • Functions Of Papillomavirus E6National Cancer Institute2010
  • Small Molecule Inhibitors Of Oncogenic Human PapillomavirusNational Cancer Institute2008–2010
  • Testing Compounds That Increase SMN Levels For Efficacy In Mouse Models Of SMANational Institute Of Neurological Disorders And Stroke2009
  • Optimization Of Drug-Like Compounds For Treatment Of Spinal Muscular AtrophyEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2009
  • Control Of Papillomavirus Expression And TransformationNational Cancer Institute2002–2009
  • High Throughput Screen For SMANational Institute Of Mental Health2008
  • Functions Of Human Papillomavirus E6National Cancer Institute2004–2008
  • High Throughput Screen For Compounds To Treat Papillomavirus Induced CancersNational Cancer Institute2006–2007
  • Papillomavirus Inhibitors For Aids-Related MalignanciesNational Cancer Institute2002–2005
  • Molecular Pathogenesis Of Spinal Muscular AtrophyNational Institute Of Neurological Disorders And Stroke2001–2004
  • Functions Of The Human Papillomavirus E6 OncoproteinNational Cancer Institute2001
  • Molecular Pathogenesis Of Spinal Muscular AtrophyNational Institute Of Neurological Disorders And Stroke2000–2001
  • Core--Aids Related MalignancyNational Institute Of Allergy And Infectious Diseases1998–2001
  • Functions Of The Human Papillomavirus E6 OncoproteinNational Cancer Institute1997–2001
  • Control Of Papillomavirus Expression And TransformatioNational Cancer Institute2000
  • Control Of Papillomavirus Expression And TransformationNational Cancer Institute1993–1999
  • Design Of Human Papillomavirus InhibitorsNational Institute Of Allergy And Infectious Diseases1995–1998
  • Papillomavirus E6 ProteinsNational Cancer Institute1994
  • Characterization Of Papillomavirus E6 ProteinsNational Cancer Institute1987–1993

Professional Memberships